Jeena Sikho Lifecare Limited has received in-principle approval from BSE Limited to list up to 6,50,000 equity shares under its Employee Stock Option Scheme 2024. This development completes the regulatory requirement for dual-exchange listing of shares arising from employee stock option exercises.

The approval was granted by BSE vide letter Ref. No. DCS/ESOP/IP/RD/239/2026-27 dated September 22, 2026. The company had previously secured similar in-principle approval from the National Stock Exchange of India Limited on March 14, 2024, when the company was listed solely on NSE.

Share count adjustment due to stock split

The number of equity shares approved for listing reflects a prior corporate action. The original scheme covered 1,30,000 equity shares with a face value of ₹10 each. Following the sub-division of the company's equity shares from a face value of ₹10 to ₹2, the eligible share count adjusted proportionally to 6,50,000 shares.

Regulatory compliance and conditions

The listing is subject to several conditions outlined by BSE. The company must notify the exchange upon allotment of shares and credit to beneficiary accounts or dispatch of share certificates. Additionally, payment of prescribed fees and compliance with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 are mandatory.

The exchange retains the right to withdraw in-principle approval if submitted information is found incomplete, incorrect, or misleading. Trading permission will be issued only after receipt of the final notification under Regulation 10(c) of the SEBI SBEB Regulations.

Jeena Sikho Lifecare Limited will participate in the "Bharat Connect Conference: Rising Stars – March 2026" on Tuesday, September 29, 2026. The company's management will engage with analysts and investors in a virtual meeting hosted by Arihant Capital Markets Limited.

The interaction is scheduled to begin at 11:00 am. This event falls under the disclosure requirements of Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Meeting Details

The company stated that the schedule is indicative and subject to changes due to unforeseen developments by either the company or the organizer. Management will refer to publicly available documents during the discussion.

Disclosure Compliance

Jeena Sikho Lifecare confirmed that no unpublished price sensitive information (UPSI) is intended to be discussed during the interaction. The intimation has been filed with both the National Stock Exchange of India Limited and BSE Limited. The notice was signed by Manish Grover, Managing Director, on September 22, 2026.